Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.68 USD
Change Today +0.54 / 7.56%
Volume 492.9K
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - LEXICON PHARMACEUTICALS INC (LXRX)

Lexicon Pharmaceuticals, Inc. to Report Q1, 2015 on Apr 29, 2015
CapIQ 04/29/2015 9:00 PM ET
Lexicon Pharmaceuticals, Inc. to Report Q4, 2014 on Mar 04, 2015
CapIQ 04/29/2015 9:00 PM ET
Lexicon Pharmaceuticals, Inc. to Report Q3, 2014 on Nov 04, 2014
CapIQ 04/29/2015 9:00 PM ET

2013 revenues at Lexicon Pharmaceuticals, Inc. totaled $2.2M USD, while annual losses equaled $0.20 per share.

Quarterly Earnings & Estimates - LEXICON PHARMACEUTICALS INC (LXRX)

Actuals vs. Estimates for LEXICON PHARMACEUTICALS INC LXRX

Lexicon Pharmaceuticals, Inc.'s Quarterly Earnings

Lexicon Pharmaceuticals, Inc. reported 2nd quarter 2014 losses of $0.05 per share on 08/9/2014.

Annual Earnings & Estimates - LEXICON PHARMACEUTICALS INC (LXRX)

Actuals vs. Estimates for LEXICON PHARMACEUTICALS INC LXRX

Lexicon Pharmaceuticals, Inc.'s Annual Earnings

Lexicon Pharmaceuticals, Inc. reported annual 2013 losses of $0.20 per share on 03/2/2014.

Quarterly Revenues - LEXICON PHARMACEUTICALS INC (LXRX)

Actuals vs. Estimates for LEXICON PHARMACEUTICALS INC LXRX

Lexicon Pharmaceuticals, Inc.'s Quarterly Revenues

Lexicon Pharmaceuticals, Inc. had 2nd quarter 2014 revenues of $676.0K USD. This bettered the $116.4K USD consensus of the 7 analysts covering the company. This was 215.9% above the prior year's 2nd quarter results.

Annual Revenues - LEXICON PHARMACEUTICALS INC (LXRX)

Actuals vs. Estimates for LEXICON PHARMACEUTICALS INC LXRX

Lexicon Pharmaceuticals, Inc.'s Annual Revenues

Lexicon Pharmaceuticals, Inc. had revenues for the full year 2013 of $2.2M USD. This was 104.0% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $7.68 USD +0.54

LXRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $49.03 USD -0.31
Boston Scientific Corp $17.83 USD -0.04
CR Bard Inc $171.95 USD -0.43
Johnson & Johnson $101.35 USD -1.07
Medtronic PLC $77.82 USD -0.59
View Industry Companies
 

Industry Analysis

LXRX

Industry Average

Valuation LXRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 32.6x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.